How long does it usually take to stop taking cycloserine?

Cycloserine (Cycloserine) is an antibiotic used to treat multidrug-resistant tuberculosis (especially multidrug-resistant tuberculosisMDR-TB) and non-tuberculous mycobacterial infections. Its structure is similar to D-alanine and can inhibit the synthesis of bacterial cell walls, so it is highly active against Mycobacterium tuberculosis in the antibacterial spectrum. The use cycle of cycloserine is not generalized. The length of treatment mainly depends on the patient's infection type, severity of illness, drug resistance spectrum, combined drug regimen, and clinical response. When treating multidrug-resistant pulmonary tuberculosis, cycloserine is often used as one of the second-line drugs and needs to be used in combination with a variety of other drugs. The course of treatment is often relatively long, usually no less than 18 to 24 months.

In the standardizedMDR-TB treatment regimen, cycloserine is often used in the intensive phase (first 6-8 months) and the continuous phase (last 12-18 months) of combined treatment until the completion of the treatment course. If the pathogenic bacteria are sensitive to cycloserine and the patient tolerates it well, its administration may last throughout the entire course of treatment; if adverse reactions to the nervous system occur midway, such as anxiety, insomnia, depression, spasm, etc., the dose needs to be reduced or discontinued based on the severity. WHO and national guidelines recommend regular evaluation of drug efficacy and side effects during treatment to determine whether to continue using cycloserine. Especially in patients with underlying diseases such as epilepsy, severe mental illness, or chronic kidney disease, their use needs to be more cautious, and blood concentration and neuropsychiatric symptoms need to be closely monitored.

For non-tuberculous mycobacterial infections or other rare uses, the treatment course of cycloserine may be slightly shorter, but the principle of "individualized treatment + efficacy monitoring" is still emphasized. During the entire treatment process, it should be dynamically managed by experienced tuberculosis specialists, and the treatment course should not be interrupted or shortened without authorization, otherwise it may lead to an increase in drug resistance or an increased risk of relapse. To sum up, the medication time for cycloserine mostly ranges from several months to two years, and needs to be scientifically adjusted according to the individual condition, combined drugs and efficacy to achieve maximum therapeutic benefit and minimum risk of toxicity.

Reference materials:https://en.wikipedia.org/wiki/Cycloserine